A citation-based method for searching scientific literature

Fei Ma, Huihui Li, Haijuan Wang, Xiuqing Shi, Ying Fan, Xiaoyan Ding, Chen Lin, Qimin Zhan, Haili Qian, Binghe Xu. Cancer Lett 2014
Times Cited: 80







List of co-cited articles
773 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prospective identification of tumorigenic breast cancer cells.
Muhammad Al-Hajj, Max S Wicha, Adalberto Benito-Hernandez, Sean J Morrison, Michael F Clarke. Proc Natl Acad Sci U S A 2003
33

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D Lehmann, Joshua A Bauer, Xi Chen, Melinda E Sanders, A Bapsi Chakravarthy, Yu Shyr, Jennifer A Pietenpol. J Clin Invest 2011
30

Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
21

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
Christophe Ginestier, Min Hee Hur, Emmanuelle Charafe-Jauffret, Florence Monville, Julie Dutcher, Marty Brown, Jocelyne Jacquemier, Patrice Viens, Celina G Kleer, Suling Liu,[...]. Cell Stem Cell 2007
20

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Sara Ricardo, André Filipe Vieira, Renê Gerhard, Dina Leitão, Regina Pinto, Jorge F Cameselle-Teijeiro, Fernanda Milanezi, Fernando Schmitt, Joana Paredes. J Clin Pathol 2011
369
18

The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Gabriella Honeth, Pär-Ola Bendahl, Markus Ringnér, Lao H Saal, Sofia K Gruvberger-Saal, Kristina Lövgren, Dorthe Grabau, Mårten Fernö, Ake Borg, Cecilia Hegardt. Breast Cancer Res 2008
408
18

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.
Giampaolo Bianchini, Justin M Balko, Ingrid A Mayer, Melinda E Sanders, Luca Gianni. Nat Rev Clin Oncol 2016
18

CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Michael O Idowu, Maciej Kmieciak, Catherine Dumur, Regina S Burton, Margaret M Grimes, Celeste N Powers, Masoud H Manjili. Hum Pathol 2012
174
16

Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.
Suling Liu, Yang Cong, Dong Wang, Yu Sun, Lu Deng, Yajing Liu, Rachel Martin-Trevino, Li Shang, Sean P McDermott, Melissa D Landis,[...]. Stem Cell Reports 2013
612
16

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
16

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
16

Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer.
Huihui Li, Fei Ma, Haijuan Wang, Chen Lin, Ying Fan, Xueyan Zhang, Haili Qian, Binghe Xu. Int J Biol Markers 2013
44
29

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Cornelia Liedtke, Chafika Mazouni, Kenneth R Hess, Fabrice André, Attila Tordai, Jaime A Mejia, W Fraser Symmans, Ana M Gonzalez-Angulo, Bryan Hennessy, Marjorie Green,[...]. J Clin Oncol 2008
15

The epithelial-mesenchymal transition generates cells with properties of stem cells.
Sendurai A Mani, Wenjun Guo, Mai-Jing Liao, Elinor Ng Eaton, Ayyakkannu Ayyanan, Alicia Y Zhou, Mary Brooks, Ferenc Reinhard, Cheng Cheng Zhang, Michail Shipitsin,[...]. Cell 2008
15

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.
Matthew D Burstein, Anna Tsimelzon, Graham M Poage, Kyle R Covington, Alejandro Contreras, Suzanne A W Fuqua, Michelle I Savage, C Kent Osborne, Susan G Hilsenbeck, Jenny C Chang,[...]. Clin Cancer Res 2015
666
15

Triple-negative breast cancer.
William D Foulkes, Ian E Smith, Jorge S Reis-Filho. N Engl J Med 2010
15

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
Brian D Lehmann, Bojana Jovanović, Xi Chen, Monica V Estrada, Kimberly N Johnson, Yu Shyr, Harold L Moses, Melinda E Sanders, Jennifer A Pietenpol. PLoS One 2016
596
15

Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.
So Yeon Park, Hee Eun Lee, Hailun Li, Michail Shipitsin, Rebecca Gelman, Kornelia Polyak. Clin Cancer Res 2010
296
13

The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.
Lauren L C Marotta, Vanessa Almendro, Andriy Marusyk, Michail Shipitsin, Janina Schemme, Sarah R Walker, Noga Bloushtain-Qimron, Jessica J Kim, Sibgat A Choudhury, Reo Maruyama,[...]. J Clin Invest 2011
667
12

Stem cells, cancer, and cancer stem cells.
T Reya, S J Morrison, M F Clarke, I L Weissman. Nature 2001
12

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.
Chad J Creighton, Xiaoxian Li, Melissa Landis, J Michael Dixon, Veronique M Neumeister, Ashley Sjolund, David L Rimm, Helen Wong, Angel Rodriguez, Jason I Herschkowitz,[...]. Proc Natl Acad Sci U S A 2009
11


The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
Lisa A Carey, E Claire Dees, Lynda Sawyer, Lisa Gatti, Dominic T Moore, Frances Collichio, David W Ollila, Carolyn I Sartor, Mark L Graham, Charles M Perou. Clin Cancer Res 2007
10

TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer.
Neil E Bhola, Justin M Balko, Teresa C Dugger, María Gabriela Kuba, Violeta Sánchez, Melinda Sanders, Jamie Stanford, Rebecca S Cook, Carlos L Arteaga. J Clin Invest 2013
402
10

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
10

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes.
Hiroko Masuda, Keith A Baggerly, Ying Wang, Ya Zhang, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam, Vicente Valero, Brian D Lehmann, Jennifer A Pietenpol, Gabriel N Hortobagyi,[...]. Clin Cancer Res 2013
440
8

Molecular definition of breast tumor heterogeneity.
Michail Shipitsin, Lauren L Campbell, Pedram Argani, Stanislawa Weremowicz, Noga Bloushtain-Qimron, Jun Yao, Tatiana Nikolskaya, Tatiana Serebryiskaya, Rameen Beroukhim, Min Hu,[...]. Cancer Cell 2007
8

Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
8

Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity.
Christine L Chaffer, Nemanja D Marjanovic, Tony Lee, George Bell, Celina G Kleer, Ferenc Reinhardt, Ana C D'Alessio, Richard A Young, Robert A Weinberg. Cell 2013
590
8

Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells.
Debangshu Samanta, Daniele M Gilkes, Pallavi Chaturvedi, Lisha Xiang, Gregg L Semenza. Proc Natl Acad Sci U S A 2014
329
8

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.
Aleix Prat, Joel S Parker, Olga Karginova, Cheng Fan, Chad Livasy, Jason I Herschkowitz, Xiaping He, Charles M Perou. Breast Cancer Res 2010
8

CD44+/CD24- phenotype predicts a poor prognosis in triple-negative breast cancer.
Hui Wang, Li Wang, Ying Song, Shuhuai Wang, Xu Huang, Qijia Xuan, Xinmei Kang, Qingyuan Zhang. Oncol Lett 2017
34
20

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Wenzhe Li, Huailei Ma, Jin Zhang, Ling Zhu, Chen Wang, Yanlian Yang. Sci Rep 2017
209
8

Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells.
Gyu-Beom Jang, In-Sun Hong, Ran-Ju Kim, Su-Youn Lee, Se-Jin Park, Eun-Sook Lee, Jung Hyuck Park, Chi-Ho Yun, Jae-Uk Chung, Kyoung-June Lee,[...]. Cancer Res 2015
110
8

High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival.
Akimitsu Yamada, Takashi Ishikawa, Ikuko Ota, Mariko Kimura, Daisuke Shimizu, Mikiko Tanabe, Takashi Chishima, Takeshi Sasaki, Yasushi Ichikawa, Satoshi Morita,[...]. Breast Cancer Res Treat 2013
66
10

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer.
So-Yeon Park, Jang-Hyun Choi, Jeong-Seok Nam. Cancers (Basel) 2019
80
8

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.
Gabriela Dontu, Wissam M Abdallah, Jessica M Foley, Kyle W Jackson, Michael F Clarke, Mari J Kawamura, Max S Wicha. Genes Dev 2003
7

Phenotypic characterization of human colorectal cancer stem cells.
Piero Dalerba, Scott J Dylla, In-Kyung Park, Rui Liu, Xinhao Wang, Robert W Cho, Timothy Hoey, Austin Gurney, Emina H Huang, Diane M Simeone,[...]. Proc Natl Acad Sci U S A 2007
7

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.
Tiffany M Phillips, William H McBride, Frank Pajonk. J Natl Cancer Inst 2006
967
7

CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis.
Carol Sheridan, Hiromitsu Kishimoto, Robyn K Fuchs, Sanjana Mehrotra, Poornima Bhat-Nakshatri, Charles H Turner, Robert Goulet, Sunil Badve, Harikrishna Nakshatri. Breast Cancer Res 2006
708
7

CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer.
T J Liu, B C Sun, X L Zhao, X M Zhao, T Sun, Q Gu, Z Yao, X Y Dong, N Zhao, N Liu. Oncogene 2013
183
7

Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy.
Jiabei He, Hong-Jen Lee, Suchandrima Saha, Diane Ruan, Hua Guo, Chia-Hsin Chan. Cell Death Dis 2019
34
17

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype.
S Zhou, J D Schuetz, K D Bunting, A M Colapietro, J Sampath, J J Morris, I Lagutina, G C Grosveld, M Osawa, H Nakauchi,[...]. Nat Med 2001
7

Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy.
Fouzia Guestini, Katsuhiko Ono, Minoru Miyashita, Takanori Ishida, Noriaki Ohuchi, Saki Nakagawa, Hisashi Hirakawa, Kentaro Tamaki, Yasuyo Ohi, Yoshiaki Rai,[...]. Breast Cancer Res Treat 2019
15
40

Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2.
Arunkumar Arumugam, Ramadevi Subramani, Sushmita Bose Nandy, Daniel Terreros, Alok Kumar Dwivedi, Edward Saltzstein, Rajkumar Lakshmanaswamy. Exp Mol Med 2019
34
17

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.
Peter Schmid, Sylvia Adams, Hope S Rugo, Andreas Schneeweiss, Carlos H Barrios, Hiroji Iwata, Véronique Diéras, Roberto Hegg, Seock-Ah Im, Gail Shaw Wright,[...]. N Engl J Med 2018
7


Triple-negative breast cancer molecular subtyping and treatment progress.
Li Yin, Jiang-Jie Duan, Xiu-Wu Bian, Shi-Cang Yu. Breast Cancer Res 2020
301
7

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.
Dario Ponti, Aurora Costa, Nadia Zaffaroni, Graziella Pratesi, Giovanna Petrangolini, Danila Coradini, Silvana Pilotti, Marco A Pierotti, Maria Grazia Daidone. Cancer Res 2005
6

Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells.
Seog-Young Kim, Jin Wook Kang, Xinxin Song, Bo Kyoung Kim, Young Dong Yoo, Yong Tae Kwon, Yong J Lee. Cell Signal 2013
190
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.